Mutational analysis of a Chinese family with oculocutaneous albinism type 2

Wang, Xiong; Zhu, Yaowu; Shen, Na; Peng, Jing; Wang, Qianqian; Liu, Haiyi; Lu, Yanjun

doi:10.18632/oncotarget.19697

Cited by 3 publications

(1 citation statement)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Among these variants, the 2.7 kb deletion on exon 7 of the OCA2 gene is the most common variant in Africans, African Americans, Haitians, and Congolese. This deletion causes a frame‐shift mutation in the first luminal loop of the OCA2 protein, resulting in the production of a non‐functional truncated protein (Mavinga et al., 2022; Stevens et al., 1997; Wang et al., 2017). Other extensively studied pathogenic variants in OCA2 include p.V443I, p.P743L and p.A481T.…”

Section: Discussionmentioning

confidence: 99%

Novel compound heterozygous mutations in OCA2 gene were identified in a Chinese family with oculocutaneous albinism

Jiang,

Zhang,

Kan

et al. 2023

Molec Gen & Gen Med

View full text Add to dashboard Cite

BackgroundOculocutaneous albinism (OCA) is a group of rare autosomal recessive disorders characterized by clinical genetic heterogeneity. OCA type II (OMIM: 203200) is the most common subtype among African and African Americans, primarily caused by pathogenic variants in the OCA2 (HGNC ID: 8101) gene. In this study, we presented a Chinese family with OCA and reported two novel variants in the OCA2 gene.MethodsWhole‐exome sequencing (WES) was performed to identify pathogenic variants in the proband. The candidate variants were subsequently validated using Sanger sequencing and QPCR assay. Additionally, bioinformatics analyses were employed to predict the deleteriousness and conservation of the identified mutations.ResultsIn the 16‐year‐old male proband, two novel compound heterozygous OCA2 variants, NM_000275.3: c.1640T>G (NP_000266.2: p.L547R) and an exons 10‐19 deletion variant, were identified. Meanwhile, a reported heterozygous variant c.1441G>A/p.A481T (NM_000275.3, NP_000266.2) in the OCA2 gene was also found in the proband. Sanger sequencing confirmed that the two variants c.1441G>A/p.A481T and c.1640T>G/p.L547R were inherited from his father. Moreover, qPCR assay revealed that the exons 10‐19 deletion was inherited from the mother, his sister also carried this variant. Fortunately, the variant was not detected in the amniotic fluid of the proband's sister. Multiple online bioinformatics tools predicted the variant c.1640T>G to be damaging, leading to the replacement of a highly conserved leucine with an arginine. The gross exon 10‐19 deletion in the OCA2 gene resulted in a truncated, non‐functional protein losing the 3–9 transmembrane α‐helices domains. According to the American College of Medical Genetics and Genomics classification, these three variants in the OCA2 gene were evaluated as likely pathogenic.ConclusionThis study has identified two novel compound variants in the OCA2 gene and a previously reported variant in a Chinese family with OCA. By expanding the mutation spectrum of the OCA2 gene, our findings contribute to a better understanding of the genetic basis of OCA.

show abstract

Section: Discussionmentioning

confidence: 99%